Search Result "EGFR/PI3K/AKT pathway"
Roles of EGFR, PI3K, AKT, and mTOR in Heavy Metal-Induced Cancer
Journal: Current Cancer Drug Targets
Volume: 13 Issue: 3 Year: 2013 Page: 252-266
Author(s): Richard L. Carpenter, Bing-Hua Jiang
EGF/EGFR Promotes Salivary Adenoid Cystic Carcinoma Cell MalignantNeural Invasion via Activation of PI3K/AKT and MEK/ERK Signaling
Journal: Current Cancer Drug Targets
Volume: 22 Issue: 7 Year: 2022 Page: 603-616
Author(s):
Targeting the Epidermal Growth Factor Pathway as Therapy for Glioblastoma
Journal: Current Cancer Therapy Reviews
Volume: 7 Issue: 1 Year: 2011 Page: 65-77
Author(s): Eudocia C. Quant, Catherine L. Nutt, Daphne Wang, Tracy T. Batchelor
Saikosaponin-A Exhibits Antipancreatic Cancer Activity by Targeting theEGFR/PI3K/Akt Pathway
Journal: Current Pharmaceutical Biotechnology
Volume: 24 Issue: 4 Year: 2023 Page: 579-588
Author(s):
Polyphyllin II Restores Sensitization of the Resistance of PC-9/ZD Cells to Gefitinib by a Negative Regulation of the PI3K/Akt/mTOR Signaling Pathway
Journal: Current Cancer Drug Targets
Volume: 17 Issue: 4 Year: 2017 Page: 376-385
Author(s): Ruzhen Zheng,Hao Jiang,Jinhui Li,Xinge Liu,Hongwei Xu
Recent Patents Related to Phosphorylation Signaling Pathway on Cancer
Journal: Recent Patents on DNA & Gene Sequences (DIscontinued)
Volume: 5 Issue: 3 Year: 2011 Page: 175-184
Author(s): Karina B. Acosta, Maria M. Tibolla, Maria M. Tiscornia, Maria A. Lorenzati, Pedro D. Zapata
The EGFR Pathway Regulates BCRP Expression in NSCLC Cells: Role of Erlotinib
Journal: Current Drug Targets
Volume: 15 Issue: 14 Year: 2014 Page: 1322-1330
Author(s): Letizia Porcelli,Elisa Giovannetti,Yehuda G. Assaraf,Gerrit Jansen,George L. Scheffer,Ietje Kathman,Amalia Azzariti,Angelo Paradiso,Godefridus J. Peters
Momordica charantia Seed and Aryl Extracts Potentiate Growth Inhibition and Apoptosis by Dual Blocking of PI3K/AKT and MAPK Pathways as a Downstream Target of EGFR Signaling in Breast Cancer Cells
Journal: Current Nutrition & Food Science
Volume: 16 Issue: 5 Year: 2020 Page: 726-733
Author(s): Guzide Satir Basaran,Hatice Bekci,Ayse Baldemir,Selen Ilgun,Ahmet Cumaoglu
Lapatinib as a Chemotherapeutic Drug
Journal: Recent Patents on Anti-Cancer Drug Discovery
Volume: 4 Issue: 3 Year: 2009 Page: 216-226
Author(s): Oluwakemi Obajimi
Dual EGFR and COX-2 Inhibition as a Novel Approach to Targeting Head and Neck Squamous Cell Carcinoma
Journal: Current Cancer Drug Targets
Volume: 9 Issue: 8 Year: 2009 Page: 931-937
Author(s): J. Kao, A. T. Sikora, S. Fu